The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...

Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help ...

Medically reviewed by Archana Sharma, DO Diagnosing multiple myeloma, also referred to as myeloma, is often a complex process. While this rare blood cancer can cause many complications, it can't be ...

Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous ...

PCL represents a minority of cases of plasma cell myeloma, accounting for 0.6–4% of all cases, [1, 2] although the latter may represent the referral bias seen in single institution retrospective ...

Multiple myeloma is a type of blood cancer that begins in plasma cells found in the bone marrow. About 20% of patients have a genetic change called t (4;14), which makes the NSD2 gene highly active.

Primary plasma cell leukemia (PCL) is the most aggressive monoclonal gammopathy. It was formerly characterized by ≥ 20% circulating plasma cells (CTCs) until 2021, when this threshold was decreased to ...